New perspectives of valproic acid in clinical practice

Author： Činčárová Lenka   Zdráhal Zbyněk   Fajkus Jiří  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.12, 2013-12, pp. : 1535-1547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results

By Berendsen Sharon   Broekman Marike   Seute Tatjana   Snijders Tom   van Es Corine   de Vos Filip   Regli Luca   Robe Pierre  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1391-1415

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients

By Desoky Ehab   Fuseau Eliane   Din Amry Salah   Cosson Valérie  

European Journal of Clinical Pharmacology, Vol. 59, Iss. 11, 2004-01 ,pp. : 783-790

Springer Publishing Company

Access to resources Recommend Favorite

Coagulation disorders with valproic acid in children

By  

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Valproic acid: Encephalopathy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1128, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Valproic acid: Hypothyroidism: case report

By  

Reactions Weekly, Vol. 1, Iss. 1197, 2008-01 ,pp. : 44-44

Adis International

Access to resources Recommend Favorite